Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
Public Markets
A Crunchbase analysis of 17 venture-funded companies from China that went public on Nasdaq and the New York Stock Exchange in the past two years...
A Crunchbase survey of six venture-backed companies in the clothing and accessories industry that went public last year shows an average post-IPO...
North American startup investment for the third quarter plummeted by more than half, driven by an even steeper drop in late-stage financing. The...
Startups that quickly rise to unicorn status often can't sustain the high valuations. We look at the ways fast unicorns can rise and fall.
Palo Alto, California-based TripActions has confidentially filed to go public next year. The company is aiming for a $12 billion valuation in Q2 of...
Cambridge, Massachusetts-based Third Harmonic Bio joined fellow sector IPOs by Seattle-based Know Labs and Texas-based BioAffinity Technologies.
With the end of the fiscal year in sight, writes Manhattan Venture Partners' Jared Carmel, companies that may have intended to go public earlier this...
Despite their deep coffers, tech companies Apple, Amazon, Google and Microsoft, AKA the “Big Four,” have made just five acquisitions of private...
Connected fitness isn’t the buzzy space it was a year or two ago, but deals are still getting done at a pretty brisk pace. We decided to take a look...
It took a $22.7 billion loss to do it, but finally SoftBank has offered something conspicuously absent from the current boom-to-bust cycle of unicorn...
Featured
CTA
Find the right companies, identify the right contacts, and connect with decision-makers with an all-in-one prospecting solution.
67.1K Followers